Bhadra Hamal
Orthopaedic
Resident
NAMS, Bir Hospital
DIABETES IN
ORTHOPAEDICS-DIABETIC
FOOT
 Diabetes mellitus-
refers to a group of common metabolic
disorders that share the phenotype of
hyperglycemia
Diagnosed by symptoms of diabetes and a two
hour plasma glucose >11.1mmol/l
(200mg/dl)and a fasting glucose>7.0mmol/l
(126mg/dl)(WHO criteria)
Complications of diabetes
 Retinopathy(nonproliferat
ive/proliferative)
Macular edema
 Neuropathy Sensory
and motor (mono- and
polyneuropathy)
 Autonomic Nephropathy
 Angiopathy:
 Coronary artery disease
 Peripheral arterial
disease
 Cerebrovascular disease
 Gastrointestinal
(gastroparesis,
diarrhea)
 Genitourinary
(uropathy/sexual
dysfunction)
 Dermatologic
 Infections
 Cataracts
 Glaucoma
 Periodontal disease
 MUSCULOSKELE
TAL
DIABETIC FOOT
 Ancient Egyptian
prostheses of big
toe
 Lancet
2000;356:2176-79
Risk factors for Diabetic foot
 NEUROPATHY
 VASCULOPATHY
 IMMUNOPATHY
NEUROPATHY
 Different metabolic pathways activated by
excess glucose- reactive oxygen
species(ROS) ie, nitric oxide, hydrogen
peroxide, advanced glycosylation end
products such as HbA1c
 ROS cause damage by causing nerve
ischemia affecting protein and cell lipids and
injuring nuclear material leading to increased
apoptosis
 Advanced glycosylation end products, by
binding cellular receptors decrease the cells
ability to detoxify itself
 Nerve myelinization can be affected, along
with injury to nerve ion channel which
decrease conduction velocity
 Microvascular disease also damage nerves
 When large sensory fibres are affected protective
sensation can be lost
 Small fibres afferent neuropathy can lead to
increased pain generation
 Motor neuropathy can cause claw toes –
ulcerations over bony prominences
 When sympathetic nervous system is affected
,skin becomes dry and scaly-cracks in skin-
invasion by bacteria
VASCULOPATHY
 Advanced glycosylation end products can
damage vascular endothelium leading to
microthrombosis and capillary obstruction,also
increase LDL which cause atherosclerosis
 Vascular tone loss due to Reactive oxygen
species(ROS)
IMMUNOPATHY
 Defects in leucocyte response to infection
ie,problems with chemotaxis, adherence,
impaired fibroblast proliferation,
phagocytosis,and intracellular killing
 Impaired growth factor
80% increased risk of cellulitis
Four fold risk of osteomyelitis
Double risk of sepsis and death from infection
 DELAYED BONE HEALING
 Collagen synthesis is decreased
 Biomechanical strength of fracture callus is
lower in diabetics
 Decreased cellular proliferation at fracture site
and decreased mechanical stiffness
DIABETIC ULCER
PATHOPHYSIOLOGY
 Sensory neuropathy- loss of sensation
 Motor neuropathy- claw toes bony
prominences make skin vulnerable to
breakdown
 Achillies contracture-(due to disorganisation
of tendon fibres and calcification within
tendon) increased forefoot pressure
forefoot ulceration
 Peripheral arterial disease- ischemia
Wagner classification
 Grade 0- skin at risk
 Grade 1- superficial ulcer
 Grade 2- exposed tendon and deep structures
 Grade 3-deep ulcer with abscess or osteomyelitis
 Grade 4-partial gangrene
 Grade 5- more extensive gangrene
TREATMENT
 NONOPERATIVE
TOTAL CONTACT CASTING (TCC) is the standard
of care because it reduces plantar loads better
than a well molded shoe cast
GOAL of total contact casting is the relief of
pressure by distributing stresses over a large
surface area
TOTAL CONTACT CASTING
 Removable diabetic boots
TREATMENT
 Negative pressure wound treatment with vacuum
assisted closure
 Hyperbaric oxygen treatment
overall healing rate 76% compared with 48% without
the use of it
 Extracorporeal shockwave treatment
helpful for healing of chronic ulcer
 Antibiotic treatment-if infected
deep culture obtained after debridement; superficial
swab often yield contaminants
TREATMENT
 OPERATIVE
 Indications for urgent surgical intervention
-necrotising infections
-gangrene
-deep abscess
-Incision and drainage with thorough
debridement
-Complete excision of infected bone
TREATMENT
 Osteomyelitis of metatarsal head
-metatarsal head resection
 If osteomyelitis involve more than metatarsal
head
-ray resection
 Osteomyelitis of calcaneum secondary to ulcer
-partial calcanectomy
 Achilles lenghtening
-to decrese plantar pressure
CHARCOT ARTHROPATHY
 HISTORY
Prof Jean-Martin
Charcot
(1825-1893)
French Neurologist and
professor of anatomical
pathology
First described in
patient with Tabes
CHARCOT ARTHROPATHY
 Diabetes – most common cause
 Others - syphilis, syringomyelia, alcoholism,
stroke, congenital insensitivity to pain, spinal cord
or peripheral nerve injury, and spina bifida
 Loss of autonomic control of the vasculature 
High resting blood flow  Osteopenia, combined
with somatosensory loss of pain and
proprioception  multiple small mechanical
insults unrecognized by the patient which set the
stage for bony dissolution and loss of structural
integrity, followed by a collapse deformity
Clinical Features
 Foot swelling
 Redness
 Numbness
 Pain – not a chief complaint (if present, less
than expected)
 CRT – usually normal
 Infected charcot’s joint – warm & red
 Radiographs
 Early neuropathic arthropathy – joint widening
and stress fractures
 Progressive and late stages – further
destruction and multiple joint involvement are
seen.
 Technetium bone scan is positive
CLASSIFICATION-EICHENHOLTZ
“I CAN HOLDS”
Stage 0: No radiographic changes, marked warmth and swelling
after injury
Stage 1: Fragmentation. Erythema, warmth and swelling
of the extremity, with subluxation/dislocation of joints
and bony debris and fragmentation of subchondral
bone.
Stage 2: Coalescence. Decreased erythema, warmth and
swelling of the extremity, with absorption of fine debris,
new bone formation, and coalescence of larger
fragments.
Stage 3: Consolidation. Resolution of swelling; however,
residual deformity is present, with remodeling of bone
Anatomical classification-
BRODSKY
 Type 1: Involvement of the
tarsometatarsal joints.
 Type 2: Involvement of the Chopart
and subtalar joints.
 Type 3A: involvement of the ankle
 Type 3B: involvement of the calcaneus
 Type 4 :involvement of multiple regions
 Type 5: involvement of forefoot
TREATMENT
 NONOPERATIVE
- Orthotics: custom-molded orthotics
that accommodate the deformity, resist
progression
-Total contact casting with protected
weight bearing
DRUGS
Bisphosphonate
-may reduce bone turnover in charcot
arthropathy and help with pain relief
Calcitonin
decrease bone turnover
 OPERATIVE
-surgery required for approx
25% patients with charcots
arthropathy
GOAL
-Deformity correction and
stabilisation to create/maintain
a braceable, infection free foot
and ankle
TREATMENT
 EXOSTECTOMY-remove bony prominences
causing ulceration. It should be done only if it
doesn’t lead to further instability
 ARTHRODESIS-indicated for deformity
correction and for instability
 AMPUTATION- last resort
REFERENCES
 Campbell’s operative orthopaedics-12th edition
 Apley’s System of Orthopaedics and Fractures- 9th
edition
 Review of orthopaedics ,Miller-6th edition
 Internet
Dio bh

Dio bh

  • 1.
    Bhadra Hamal Orthopaedic Resident NAMS, BirHospital DIABETES IN ORTHOPAEDICS-DIABETIC FOOT
  • 2.
     Diabetes mellitus- refersto a group of common metabolic disorders that share the phenotype of hyperglycemia Diagnosed by symptoms of diabetes and a two hour plasma glucose >11.1mmol/l (200mg/dl)and a fasting glucose>7.0mmol/l (126mg/dl)(WHO criteria)
  • 3.
    Complications of diabetes Retinopathy(nonproliferat ive/proliferative) Macular edema  Neuropathy Sensory and motor (mono- and polyneuropathy)  Autonomic Nephropathy  Angiopathy:  Coronary artery disease  Peripheral arterial disease  Cerebrovascular disease  Gastrointestinal (gastroparesis, diarrhea)  Genitourinary (uropathy/sexual dysfunction)  Dermatologic  Infections  Cataracts  Glaucoma  Periodontal disease  MUSCULOSKELE TAL
  • 5.
    DIABETIC FOOT  AncientEgyptian prostheses of big toe  Lancet 2000;356:2176-79
  • 6.
    Risk factors forDiabetic foot  NEUROPATHY  VASCULOPATHY  IMMUNOPATHY
  • 7.
    NEUROPATHY  Different metabolicpathways activated by excess glucose- reactive oxygen species(ROS) ie, nitric oxide, hydrogen peroxide, advanced glycosylation end products such as HbA1c  ROS cause damage by causing nerve ischemia affecting protein and cell lipids and injuring nuclear material leading to increased apoptosis
  • 8.
     Advanced glycosylationend products, by binding cellular receptors decrease the cells ability to detoxify itself  Nerve myelinization can be affected, along with injury to nerve ion channel which decrease conduction velocity  Microvascular disease also damage nerves
  • 9.
     When largesensory fibres are affected protective sensation can be lost  Small fibres afferent neuropathy can lead to increased pain generation  Motor neuropathy can cause claw toes – ulcerations over bony prominences  When sympathetic nervous system is affected ,skin becomes dry and scaly-cracks in skin- invasion by bacteria
  • 10.
    VASCULOPATHY  Advanced glycosylationend products can damage vascular endothelium leading to microthrombosis and capillary obstruction,also increase LDL which cause atherosclerosis  Vascular tone loss due to Reactive oxygen species(ROS)
  • 11.
    IMMUNOPATHY  Defects inleucocyte response to infection ie,problems with chemotaxis, adherence, impaired fibroblast proliferation, phagocytosis,and intracellular killing  Impaired growth factor 80% increased risk of cellulitis Four fold risk of osteomyelitis Double risk of sepsis and death from infection
  • 12.
     DELAYED BONEHEALING  Collagen synthesis is decreased  Biomechanical strength of fracture callus is lower in diabetics  Decreased cellular proliferation at fracture site and decreased mechanical stiffness
  • 13.
    DIABETIC ULCER PATHOPHYSIOLOGY  Sensoryneuropathy- loss of sensation  Motor neuropathy- claw toes bony prominences make skin vulnerable to breakdown  Achillies contracture-(due to disorganisation of tendon fibres and calcification within tendon) increased forefoot pressure forefoot ulceration  Peripheral arterial disease- ischemia
  • 14.
    Wagner classification  Grade0- skin at risk  Grade 1- superficial ulcer  Grade 2- exposed tendon and deep structures  Grade 3-deep ulcer with abscess or osteomyelitis  Grade 4-partial gangrene  Grade 5- more extensive gangrene
  • 17.
    TREATMENT  NONOPERATIVE TOTAL CONTACTCASTING (TCC) is the standard of care because it reduces plantar loads better than a well molded shoe cast GOAL of total contact casting is the relief of pressure by distributing stresses over a large surface area
  • 18.
  • 20.
  • 21.
    TREATMENT  Negative pressurewound treatment with vacuum assisted closure  Hyperbaric oxygen treatment overall healing rate 76% compared with 48% without the use of it  Extracorporeal shockwave treatment helpful for healing of chronic ulcer  Antibiotic treatment-if infected deep culture obtained after debridement; superficial swab often yield contaminants
  • 22.
    TREATMENT  OPERATIVE  Indicationsfor urgent surgical intervention -necrotising infections -gangrene -deep abscess -Incision and drainage with thorough debridement -Complete excision of infected bone
  • 23.
    TREATMENT  Osteomyelitis ofmetatarsal head -metatarsal head resection  If osteomyelitis involve more than metatarsal head -ray resection  Osteomyelitis of calcaneum secondary to ulcer -partial calcanectomy  Achilles lenghtening -to decrese plantar pressure
  • 24.
    CHARCOT ARTHROPATHY  HISTORY ProfJean-Martin Charcot (1825-1893) French Neurologist and professor of anatomical pathology First described in patient with Tabes
  • 25.
    CHARCOT ARTHROPATHY  Diabetes– most common cause  Others - syphilis, syringomyelia, alcoholism, stroke, congenital insensitivity to pain, spinal cord or peripheral nerve injury, and spina bifida  Loss of autonomic control of the vasculature  High resting blood flow  Osteopenia, combined with somatosensory loss of pain and proprioception  multiple small mechanical insults unrecognized by the patient which set the stage for bony dissolution and loss of structural integrity, followed by a collapse deformity
  • 27.
    Clinical Features  Footswelling  Redness  Numbness  Pain – not a chief complaint (if present, less than expected)  CRT – usually normal  Infected charcot’s joint – warm & red
  • 28.
     Radiographs  Earlyneuropathic arthropathy – joint widening and stress fractures  Progressive and late stages – further destruction and multiple joint involvement are seen.  Technetium bone scan is positive
  • 30.
    CLASSIFICATION-EICHENHOLTZ “I CAN HOLDS” Stage0: No radiographic changes, marked warmth and swelling after injury Stage 1: Fragmentation. Erythema, warmth and swelling of the extremity, with subluxation/dislocation of joints and bony debris and fragmentation of subchondral bone. Stage 2: Coalescence. Decreased erythema, warmth and swelling of the extremity, with absorption of fine debris, new bone formation, and coalescence of larger fragments. Stage 3: Consolidation. Resolution of swelling; however, residual deformity is present, with remodeling of bone
  • 32.
    Anatomical classification- BRODSKY  Type1: Involvement of the tarsometatarsal joints.  Type 2: Involvement of the Chopart and subtalar joints.  Type 3A: involvement of the ankle  Type 3B: involvement of the calcaneus  Type 4 :involvement of multiple regions  Type 5: involvement of forefoot
  • 33.
    TREATMENT  NONOPERATIVE - Orthotics:custom-molded orthotics that accommodate the deformity, resist progression -Total contact casting with protected weight bearing DRUGS Bisphosphonate -may reduce bone turnover in charcot arthropathy and help with pain relief Calcitonin decrease bone turnover
  • 34.
     OPERATIVE -surgery requiredfor approx 25% patients with charcots arthropathy GOAL -Deformity correction and stabilisation to create/maintain a braceable, infection free foot and ankle
  • 35.
    TREATMENT  EXOSTECTOMY-remove bonyprominences causing ulceration. It should be done only if it doesn’t lead to further instability  ARTHRODESIS-indicated for deformity correction and for instability  AMPUTATION- last resort
  • 36.
    REFERENCES  Campbell’s operativeorthopaedics-12th edition  Apley’s System of Orthopaedics and Fractures- 9th edition  Review of orthopaedics ,Miller-6th edition  Internet

Editor's Notes

  • #33  type 1:This is the most common type and often leads to the rocker-bottom deformity and plantar ulcerations secondary to bony prominences in this area. Type 2:The second most common affected area, type 2 involvement also can lead to a rocker-bottom deformity with plantar flexion of the talar head. Marked varus/valgus of the hindfoot also can develop.